Search Results: PARP inhibitors

• Science & Technology
• Health & Medicine

A 'lethal weapon' in the search for new cancer treatments?

10 July 2008

New drug trial to target hereditary cancers

Cancer Research UK scientists at Newcastle University are starting the first UK trial of a new drug which targets the 'Achilles' heel' in hereditary forms of both breast and ovarian cancer. Cancer Research UK scientists at Newcastle University are starting the first UK trial of a new drug which targets the 'Achilles' heel' in hereditary forms of both breast and ovarian cancer.

27 February 2008

Newcastle scientists host top conference in Gateshead

Newcastle scientists will play host to an international audience of researchers and doctors at a major conference in Gateshead from 5-7 October 2005. Newcastle scientists will play host to an international audience of researchers and doctors at a major conference in Gateshead from 5-7 October 2005.

4 October 2005

• Health & Medicine

New drug could help target cancer cells with deadly accuracy

A new drug that could revolutionise the impact of radiotherapy on cancer and make treatment much more effective, has been developed by Cancer Research UK scientists - it is announced today. A new drug that could revolutionise the impact of radiotherapy on cancer and make treatment much more effective, has been developed by Cancer Research UK scientists - it is announced today.

28 October 2002

• Policy & Insight

Opinion: 'Let’s not be short-sighted – the UK’s medical research charities need urgent support'

Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding. Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.

24 September 2020

• Health & Medicine

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

26 March 2020

• Health & Medicine

Advanced ovarian cancer treatment approved for Cancer Drugs Fund

A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund. A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.

11 October 2019

• Health & Medicine

Advanced ovarian cancer drug gets initial ‘no’ for NHS in England

A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England. A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.

9 August 2019

Cancer Research UK announces winners of 2013 research prizes

Cancer Research UK presented its prestigious Lifetime Achievement Award to the internationally acclaimed scientist Professor Sir Bruce Ponder. Cancer Research UK presented its prestigious Lifetime Achievement Award to the internationally acclaimed scientist Professor Sir Bruce Ponder.

5 November 2013

• Science & Technology

Researchers exploit cancer’s faulty defence mechanism

Researchers in Germany have found a new way to exploit the differences between cancer cells and normal cells that could lead to new treatments. Researchers in Germany have found a new way to exploit the differences between cancer cells and normal cells that could lead to new treatments.

12 June 2013